Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durability of Nevirapine, Stavudine, and Lamivudine in Advanced HIV
NCT00703898Phase 4Completed
- Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Start
- Nov 2004
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nevirapine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Bamrasnaradura Infectious Diseases Institute. Primary endpoint: Number of patients with undetectable plasma HIV-1 viral load at 240 weeks. Started Nov 2004; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00703898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703898.